Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development 2024-07-26 09:33
Ractigen Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy 2024-07-25 20:00
IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication -- Systemic Lupus Erythematosus (SLE) 2024-07-25 17:46
Australasian College of Pharmacy and MedAdvisor Solutions Launch MedAdvisor software training for the Queensland Community Pharmacy Scope of Practice Pilot 2024-07-25 05:00
Telix Successfully Prices A$650 Million Convertible Bonds 2024-07-24 07:51
Telix Announces A$600 Million Convertible Bonds Offering 2024-07-23 16:35
Linical Named Best Global CRO by Global Health & Pharma Magazine 2024-07-23 09:00
QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs 2024-07-23 08:00
Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million 2024-07-23 01:23
Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency 2024-07-22 19:48
Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial 2024-07-22 19:00
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis 2024-07-22 09:00
Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors 2024-07-22 08:00
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA 2024-07-22 08:00
Treatment of Type 2 diabetes with Chiglitazar combined with Metformin Approved for listing by the National Medical Products Administration 2024-07-19 22:01
Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms 2024-07-19 12:30
Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results 2024-07-19 07:15
ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development 2024-07-19 00:00
Assessment of supply chain risk key to improving medicine access 2024-07-18 23:00
DX&VX is on Track and Accelerating the Development of Oral Obesity Treatment 2024-07-18 21:00
1 22 23 24 25 26 412